CACaption Management, LLC
Institutional investor · Portfolio as of Q4 2023
Top Holdings1,292 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
CYTOKINETICS INC | 1.7M | $141M | 1.9% | — | — | — | Increased — |
MONDELEZ INTERNATIONAL INC-A | 1.6M | $117.7M | 1.6% | — | — | — | New — |
T-MOBILE US INC | 716,800 | $114.9M | 1.5% | — | — | — | Increased — |
CYTOKINETICS INC | 1.4M | $112.9M | 1.5% | — | — | — | Increased — |
PALO ALTO NETWORKS INC | 329,100 | $97M | 1.3% | — | — | — | Increased — |
VERIZON COMMUNICATIONS INC | 2.6M | $96.4M | 1.3% | $32.50 | 0.00% | 1 qtr | New 68 |
KENVUE INC | 4.4M | $93.8M | 1.3% | — | — | — | Increased — |
AVI BIOPHARMA INC | 964,300 | $93M | 1.3% | — | — | — | Increased — |
SPLUNK INC | 595,500 | $90.7M | 1.2% | — | — | — | New — |
VERIZON COMMUNICATIONS INC | 2.4M | $90.5M | 1.2% | — | — | — | New — |
CITIGROUP INC | 1.8M | $90.1M | 1.2% | $38.03 | +26.20% | 2 qtrssince 2023-Q3 | Increased 48 |
CITIGROUP INC | 1.7M | $87.2M | 1.2% | — | — | — | Decreased — |
T-MOBILE US INC | 440,000 | $70.5M | 1.0% | — | — | — | Decreased — |
SPDR S&P BIOTECH ETF | 704,100 | $62.9M | 0.8% | — | — | — | Increased — |
SPDR SERIES TRUST | 1.2M | $62.5M | 0.8% | — | — | — | Increased — |
ALPHABET INC-CL C | 411,300 | $58M | 0.8% | — | — | — | Decreased — |
SPDR SERIES TRUST | 1.1M | $57.9M | 0.8% | $39.19 | +26.54% | 2 qtrssince 2023-Q3 | Decreased 0 |
VERTIV HOLDINGS CO-A | 1.2M | $57M | 0.8% | — | — | — | Increased — |
NORTHROP GRUMMAN CORP | 115,000 | $53.8M | 0.7% | — | — | — | New — |
AMERISOURCEBERGEN CORP | 260,800 | $53.6M | 0.7% | — | — | — | Decreased — |
Caption Management, LLC manages $7.4B across 1292 positions as of Q4 2023. Top holdings: CYTK (1.9%), MDLZ (1.6%), TMUS (1.5%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 222 new positions, 195 exits, 79 increased. Top move: VZ (NEW, conviction 68). Portfolio: $7.4B across 1292 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer